Teladoc HealthTDOC
TDOC
0
Funds holding %
of 7,419 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
38% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 55
13% more call options, than puts
Call options by funds: $65.6M | Put options by funds: $58.3M
11% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 100
4% more funds holding
Funds holding: 358 [Q3] → 373 (+15) [Q4]
0.36% more ownership
Funds ownership: 73.22% [Q3] → 73.58% (+0.36%) [Q4]
0% more capital invested
Capital invested by funds: $1.15B [Q3] → $1.15B (+$2.14M) [Q4]
100% less funds holding in top 10
Funds holding in top 10: 2 [Q3] → 0 (-2) [Q4]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$8
23%
upside
Avg. target
$10.83
66%
upside
High target
$13
100%
upside
6 analyst ratings
4 positive
67%
2 neutral
33%
0 negative
0%
Jefferies Glen Santangelo 45% 1-year accuracy 5 / 11 met price target | 23%upside $8 | Hold Maintained | 21 Apr 2025 |
B of A Securities Allen Lutz 53% 1-year accuracy 8 / 15 met price target | 23%upside $8 | Neutral Maintained | 11 Apr 2025 |
Goldman Sachs David Roman 25% 1-year accuracy 5 / 20 met price target | 100%upside $13 | Buy Maintained | 3 Mar 2025 |
Piper Sandler Jessica Tassan 35% 1-year accuracy 8 / 23 met price target | 84%upside $12 | Overweight Maintained | 27 Feb 2025 |
RBC Capital Sean Dodge 26% 1-year accuracy 9 / 34 met price target | 84%upside $12 | Outperform Maintained | 24 Jan 2025 |
Financial journalist opinion
Based on 6 articles about TDOC published over the past 30 days
Negative
Seeking Alpha
5 days ago
Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade)
Teladoc Health, Inc.'s stock has declined significantly, from a high of $14 per share in February to $7 per share, with ongoing financial struggles and underperformance in key segments. The company reported a net loss of $1 billion in 2024, with declining revenues in its BetterHelp segment and minimal growth in Integrated Care. Despite efforts to cut costs and new initiatives like the Catapult Health acquisition and a partnership with Eli Lilly, Teladoc's value proposition remains unclear.
Negative
The Motley Fool
1 week ago
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. It's a great strategy, but it's essential to avoid those companies that only look undervalued but actually aren't.
Neutral
GlobeNewsWire
1 week ago
Teladoc Health Introduces Next Generation Cardiometabolic Health Program
PURCHASE, NY, April 08, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today introduced its next generation Cardiometabolic Health Program to improve population health and prevent the progression of diabetes, hypertension and obesity. Building on the company's industry-leading chronic condition management programs, the new offering is designed to support optimal cardiometabolic health for all populations.
Positive
The Motley Fool
3 weeks ago
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks?
Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies.
Negative
Zacks Investment Research
3 weeks ago
Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
Negative
Zacks Investment Research
3 weeks ago
Teladoc (TDOC) Flat As Market Sinks: What You Should Know
Teladoc (TDOC) reachead $8.64 at the closing of the latest trading day, reflecting no change compared to its last close.
Neutral
Zacks Investment Research
1 month ago
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider
In the latest trading session, Teladoc (TDOC) closed at $8.49, marking a +1.19% move from the previous day.
Neutral
Accesswire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
PRNewsWire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK , March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
The Motley Fool
1 month ago
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy?
Telemedicine specialist Teladoc Health (TDOC 1.53%) has been a terrible investment over the past three years. Once the company's pandemic-fueled business boom cooled down, its revenue and visit growth slowed down considerably while it remained unprofitable.
Charts implemented using Lightweight Charts™